People In The News: EFPIA Seeks New Leader, Medicines Australia Finds One
EFPIA's Richard Bergström is moving on; Medicines Australia brings in UK-based lobbyist Milton Catelin as its CEO; Friends of Cancer Research promotes Jeff Allen to CEO, plus more biopharma personnel changes.
You may also be interested in...
Jim O'Neill says he spends sleepless nights worrying whether his Review of Antimicrobial Resistance (AMR) will run out of steam once completed in two months' time - but he's encouraged by growing evidence world leaders and the pharma industry are seriously embracing the theme and will soon make lasting commitments to effectively combat antibiotic resistance, including in Asia.
Tim James has resigned as CEO of the pharmaceutical industry body Medicines Australia, effective from January 20161. The search for a successor will begin next year.
ABHI’s Phil Brown believes the future of UK device regulation will be innovation-friendly and patient-responsive system – but doesn’t expect easy alignment with the EU. See what he had to say.